Odyssey Health Inc (ODYY) Stock Price, Trades & News

Odyssey Health Inc is a developing medical and pharmaceutical technology that solves unmet clinical needs and has a substantial market opportunity. Its medical devices include CardioMap and Save-A-Life.

Financial Strength

Name	Current	Vs Industry
Cash-To-Debt	0.11
Equity-to-Asset	-26.07
Debt-to-Equity	-0.27
Debt-to-EBITDA	-1.07
Piotroski F-Score	3/9	0 1 2 3 4 5 6 7 8 9
WACC vs ROIC		WACC ROIC

Growth Rank

	Name	Current	Vs Industry		Vs History
	3-Year EBITDA Growth Rate	45.2
	3-Year EPS without NRI Growth Rate	43.8
	3-Year FCF Growth Rate	56.3
	3-Year Book Growth Rate	-6.3

Momentum Rank

	Name	Current	Vs Industry		Vs History
	5-Day RSI	34.1
	9-Day RSI	34.86
	14-Day RSI	32.3
	3-1 Month Momentum %	-61.58
	6-1 Month Momentum %	-36.67
	12-1 Month Momentum %	60.2

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	0.04
	Quick Ratio	0.04
	Cash Ratio	0.03

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	3-Year Average Share Buyback Ratio	-7.5
	Shareholder Yield %	-45.33

Profitability Rank

	Name	Current	Vs Industry		Vs History
	ROA %	-1227.99
	ROIC %	-20.27
	3-Year ROIIC %	1736.76
	Moat Score	3
	Tariff Resilience Score	5

GF Value Rank

	Name	Current	Vs Industry		Vs History
	EV-to-EBIT	-1.24
	EV-to-EBITDA	-1.24
	EV-to-FCF	-3.29
	Earnings Yield (Greenblatt) %	-80.65
	FCF Yield %	-127.73

GF Value™

ODYY

Warning Signs

Warning! GuruFocus detected 4 Severe warning signs with ODYY. Try a 7-Day Free Trial to check it out.

Odyssey Health Inc Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Odyssey Health Inc Stock Events

Financials Calendars

Event	Date	Price ($)
First quarter earnings results for 2027	2026-12-11	In 166 days
Annual report for 2026	2026-10-29	In 123 days
General meeting for 2025	2026-06-30	In 2 days
Third quarter earnings results for 2026	2026-06-12	0.01 (-7.35%)
Second quarter earnings results for 2026	2026-03-12	0.05 (+16.85%)
First quarter earnings results for 2026	2025-12-11	0.04 (+0.00%)
Annual report for 2025	2025-10-29	0.07 (+7.87%)
Third quarter earnings results for 2025	2025-06-13	0.01 (+43.23%)
Second quarter earnings results for 2025	2025-03-14	0.01 (+0.00%)
First quarter earnings results for 2025	2024-12-16	0.03 (+7.14%)

Show

Entries

Guru Commentaries on OTCPK:ODYY

No articles.

Press Release

	Subject	Date
	Odyssey Health, Inc. Strengthens Balance Sheet with $8.7 Million in Net Equity	2024-03-27
	Odyssey Health Closes Asset Sale of its Neurological Drug Technology Pipeline Including Concussion Drug Candidate with Oragenics, Inc.	2024-01-02
	Odyssey Health, Inc. Gains Shareholder Approval for Asset Sale with Oragenics, Inc.	2023-12-12
	Odyssey Health, Inc, Selects Syneos Health to Support Investigational New Drug Application for Treatment of Concussion	2023-11-16
	Odyssey Health, Inc. to Provide Company Update and Webcast for Shareholders	2023-11-15
	Odyssey Health, Inc. Provides Update on Asset Purchase Agreement with Oragenics, Inc.	2023-10-18
	Odyssey Health Inc. Begins Trading on the OTCQB	2023-10-04
	Odyssey Health, Inc. Presents Concussion Treatment Data at the Military Health System Research Symposium - MHSRS	2023-08-23
	Odyssey Health, Inc. Presents Data at the Special Operations Medical Association - Scientific Assembly	2023-06-08
	Brett Favre Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)	2022-07-14

10/Page

Articles on Odyssey Health Inc

No articles.

Headlines

No news.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.